Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?

Can J Cardiol. 2016 Oct;32(10):1203.e9-1203.e11. doi: 10.1016/j.cjca.2016.03.011. Epub 2016 Mar 24.

Authors

Peter Leong-Sit¹, Jeffrey S Healey²

Affiliations

¹ Western University, London, Ontario, Canada. Electronic address: [email protected].
² Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

PMID: 27345609
DOI: 10.1016/j.cjca.2016.03.011

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Humans
Risk
Stroke
Warfarin*

Substances

Anticoagulants
Warfarin